Emerging paradigms in the management of malignant pleural effusions

Respiratory Medicine

Volumn 102, Issue 7, 2008, Pages 939-948

  Khaleeq, Ghulam ^a   Musani, Ali I ^b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Malignant pleural effusion; Pleural catheter; Pleurodesis

Indexed keywords

BLEOMYCIN; SCLEROSING AGENT; TALC; TETRACYCLINE;

ADULT RESPIRATORY DISTRESS SYNDROME; BLEEDING; BREAST CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; CYTODIAGNOSIS; DISEASE ASSOCIATION; DYSPNEA; EMPYEMA; ENDOSCOPIC SURGERY; FEVER; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOTENSION; INFECTION; INTERMETHOD COMPARISON; INTERSTITIAL PNEUMONIA; LIVER INJURY; LUNG CANCER; LUNG VENTILATION; LYMPHOMA; NEOPLASM; OVARY CANCER; PAIN; PATHOGENESIS; PH MEASUREMENT; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SCLEROTHERAPY; SHUNTING; SPLEEN INJURY; STOMACH CANCER; THORACOCENTESIS; THORAX DRAINAGE; THORAX PAIN; THORAX SURGERY; TREATMENT OUTCOME; TUBE;

CATHETERS, INDWELLING; CHEST TUBES; DRAINAGE; HUMANS; NEOPLASMS; PLEURAL CAVITY; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PROGNOSIS; THORACOSCOPY; TREATMENT OUTCOME;

EID: 44749094345     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.01.022     Document Type: Review

References (64)

1. Marel M., Zrustova M., Stasny B., et al. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 104 (1993) 1486-1489
2. Antony V.B., Loddenkemper R., Astoul P., et al. Management of malignant pleural effusions. Am J Respir Crit Care Med 162 (2000) 1987-2001
3. Ruckdeschel J.C. Management of malignant pleural effusions. Semin Oncol 22 (1995) 58-63
4. Sahn S.A. Malignancy metastatic to the pleura. Clin Chest Med 19 (1998) 351-361
5. Sahn S.A. Pleural diseases related to metastatic malignancies. Eur Respir J 10 (1997) 1907-1913
6. Chernow B., and Sahn S.A. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63 (1977) 695-702
7. Meyer P.C. Metastatic carcinoma of the pleura. Thorax 21 (1966) 437-443
8. Staub N.C., et al. Transport through the pleura: physiology of normal liquid and solute exchange in the pleural space. In: Chretien J., et al. (Ed). The pleura in health and disease (1985), Marcel Decker, New York
9. Yano S., Shinohara H., Herbst R.S., et al. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am J Pathol 157 (2000) 1893-1903
10. Yano S., Herbst R.S., Shinohara H., et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res 6 (2000) 957-965
11. Heffner J.E., Nietert P.J., and Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 117 (2000) 79-86
12. Aelony Y., Yao J.F., and King R.R. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage. Respiration 73 (2006) 334-339
13. Crnjac A., Sok M., and Kamenik M. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur J Cardio-Thorac Surg 26 (2004) 432-436
14. Porcel J.M., and Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 124 (2003) 978-983
15. Villena V., Perez V., Pozo F., et al. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. Chest 121 (2002) 470-474
16. Loddenkemper R., and Boutin C. Thoracoscopy: present diagnostic and therapeutic indications. Eur Respir J 6 (1993) 1544-1555
17. Chakrabarti B., Ryland I., Sheard J., et al. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest 129 (2006) 1549-1555
18. Shinto R.A., Stansbury D.W., Fischer C.E., et al. Does therapeutic thoracentesis improve the exercise capacity of patients with pleural effusion?. Am Rev Respir Dis 135 (1988) A244
19. Anderson C.B., Philpott G.W., and Ferguson T.B. The treatment of malignant pleural effusions. Cancer 33 (1974) 916-922
20. Sprung C.L., Loewenherz J.W., Baier H., et al. Evidence for increased permeability in reexpansion pulmonary edema. Am J Med 71 (1981) 497
21. McVay P.A., and Toy P.T.C.Y. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 31 (1991) 164
22. Spiegler P.A., Hurewitz A.N., and Groth M.L. Rapid pleurodesis for malignant pleural effusions. Chest 23 (2003) 1895-1898
23. Gary Lee Y.C., Teixeira L.R., Devin C.J., Vaz M., Vargas F.S., Thompson P.J., et al. Transforming growth factor-{beta}2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 163 (2001) 640-644
24. Light R.W., Cheng D., Lee Y.C.G., Rogers J., Davidson J., and Lane K.B. A single intrapleural injection of transforming growth factor-beta 2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 162 (2000) 98-104
25. Ferrer J., Montes J.F., Villarino M.A., Light R.W., and Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis*. Chest 122 (2002) 1018-1027
26. Paschoalini M.D.S., Vargas F.S., Marchi E., Pereira J.R., Jatene F.B., Antonangelo L., et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 128 2 (2005) 684-689
27. Walker-Renard P., Vaughan L.M., and Sahn S.A. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120 (1994) 56
28. Patz E.F., McAdams H.P., Erasmus J.J., et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 113 (1998) 1305
29. Heffner J.E., Standerfer R.J., Torstveit J., et al. Clinical efficacy of doxycycline for pleurodesis. Chest 105 (1994) 1743
30. Pulsiripunya C., Youngchaiyud P., Pushpakom R., et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology 1 (1996) 69
31. Kennedy L., and Sahn S.A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 106 (1994) 1215
32. Julius P.J., Gareth C., Phillippe A., et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 369 May (2007) 1535-1539
33. Tan C., Sedrakyan A., Browne J., et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardio-Thorac Surg 29 (2006) 829-838
34. Rodriguez-Panadero F., Janssen J.P., and Astoul P. Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J 28 2 (2006) 409-422
35. Tassi G.F., Davies R.J.O., and Noppen M. Advanced techniques in medical thoracoscopy. Eur Respir J 28 5 (2006) 1051-1059
36. Menzies R., and Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 114 (1991) 271-276
37. Harris R.J., Kavuru M.S., Mehta A.C., et al. The impact of thoracoscopy on themanagement of pleural disease. Chest 107 (1995) 845-852
38. Viallat J.R., Rey F., Astoul P., et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 110 (1996) 1387-1393
39. Colt H.G. Therapeutic thoracoscopy. Clin Chest Med 19 (1998) 383-394
40. Steffen K., Arndt B., and Adrian G. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest 128 (2005) 1431-1435
41. Armin E., Craig P.H., Felix H., et al. A novel instrument for the evaluation of the pleural space* an experience in 34 patients. Chest 122 (2002) 1530-1534
42. Love D., White D., and Kiroff G. Thoracoscopic talc pleurodesis for malignant pleural effusion. ANZ J Surg 73 (2003) 19-22
43. Arapis K., Caliandro R., Stern J.B., et al. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc 20 (2006) 919-923
44. Gasparri R., Leo F., Veronesi G., et al. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 106 (2006) 271-276
45. Trotter D., Aly A., Siu L., et al. Video-assisted thoracoscopic [VATS] pleurodesis for malignant effusion: an Australian teaching hospital's experience. Heart, Lung Circ 14 (2005) 93-97
46. Marrazzo A., Noto A., Casa L., et al. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J Pain Symptom Manage 30 (2005) 75-79
47. Reich H., Beattie E.J., and Harvey J.C. Pleuroperitoneal shunt for malignant pleural effusions: a one-year experience. Semin Surg Oncol 9 (1993) 160-162
48. Lee K.A., Harvey J.C., Reich H., et al. Management of malignant pleural effusions with pleuroperitoneal shunting. J Am Coll Surg 178 (1994) 586-588
49. Leff R.S., Eisenberg B., Baisden C.E., et al. Drainage of recurrent pleural effusion via an implanted port and intrapleural catheter. Ann Intern Med 104 (1986) 208-209
50. Van Le L., Parker L.A., DeMars L.R., et al. Pleural effusions: outpatient management with pigtail catheter chest tubes. Gynecol Oncol 54 (1994) 215-217
51. Zeldin D.C., and Rodriguez R.M. Management of refractory malignant pleural effusions with a chronic indwelling pleural catheter. Chest 100 (1991) 87S
52. Grodzin C.J., and Balk R.A. Indwelling small pleural catheter needle thoracentesis in the management of large pleural effusions. Chest 111 (1997) 981-988
53. Tremblay A., and Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 129 (2006) 362-368
54. Hewitt J.B., and Janssen W.R. A management strategy for malignancy-induced pleural effusion: long-term thoracostomy drainage. Oncol Nurs Forum 14 (1987) 17-22
55. Putnam Jr. J.B., Light R.W., Rodriguez R.M., et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86 (1999) 1992-1999
56. Putnam Jr. J.B., Walsh G.L., Swisher S.G., et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69 (2000) 369-375
57. Musani A.I., Haas A.R., Seijo L., et al. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 71 (2004) 559-566
58. Hewitt J.B., and Janssen W.R. A management strategy for malignancy-induced pleural effusion: long-term thoracostomy drainage. Oncol Nurs Forum 14 (1987) 17-22
59. Robinson R.D., Fullerton D.A., Albert J.D., et al. Use of pleural Tenckhoff catheter to palliate malignant pleural effusion. Ann Thorac Surg 57 (1994) 286-288
60. Pollak J.S. Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med 8 (2002) 302-307
61. Pollak J.S., Burdge C.M., Rosenblatt M., et al. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 12 (2001) 201-208
62. Fujita A., Takabatake H., Tagaki S., and Sekine K. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer: cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support. Chest 119 2 (2001) 340-343
63. Ren S., Terman D., Bohach G., Silvers A., Hansen C., Colt H., et al. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 126 5 (2004) 1529-1539
64. Scagliotti G.V., Shin D.M., Kindler H.L., et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 21 (2003) 1556